Rayca Precision
Here's How We Will Treat Cancer Diseases and Conduct Clinical Research in the Future
Rayca Is A Breakthrough In Precision Oncology and Clinical Research
Rayca is striving to implement this procedure to lower the overall risk of cancer, which poses a significant threat to patients’ lives. Eventually, this approach will become a crucial and distinctive measure in the fight against this devastating disease.
Something Revolutionary Is Being Made Here
In the realm of precision oncology medicine, the advent of High-Throughput Transcriptome Profiling and the meticulous scrutiny of patient-specific data independently bestow an unprecedented capacity to refine personalized treatments. Yet, a synergistic integration of these two cutting-edge modalities could engender an advancement of oncology medicine that surpasses the limits of imagination. By introducing two nascent phenomena whose intricacies are only beginning to be comprehended, the potential for innovative breakthroughs is nigh boundless.
A Brand New Analytical Platform for Clinical Research Industry
We believe that by supporting researchers in their quest to understand the underlying mechanisms of biology and disease, we can contribute to the advancement of knowledge, speeding up the research and ultimately improve the quality of life for people around the world.
Next Level Precision Oncology
Rayca Precision Predictive Platform to Transform Precision Oncology
Tumor Origin Detection
Classification of Tumors with Unknown Origin
Molecular Staging and Metastasis
Tumor Profiling
Prognosis Analysis and Patient Monitoring
Survival Prediction
Drug Response Prediction
Drug Pairs & Single Drug Response
Rayca is a breakthrough in Precision Oncology
Molecular Profiling
We aspire to conduct a precise analysis of the molecular characteristics of a patient, as well as their specific tumor and cancer affliction in this instance.
Accurate Predictions
We would therefore be able to accurately predict the recurrence and/or regression of tumors, as well as make valid predictions about a cancer patient’s survival in this instance.
Classification of Tumors with Unknown Origin
Classify the Types of Tumors and Identify Their Primary Location
Identifying the Origin of Tumors Through Analysis of Gene Expression Data
Read MoreMolecular Staging and Metastatic State Prediction
Accurately Predict Tumor Progression Rate and Metastasis Analysis
Cancer Staging with Genes: Matching Molecular Profile and Metastasis
Read MoreDrug Response Prediction
Pharmacogenomic Analysis
Recommend Personalized Treatments Based on a Patient's Genetic Footprint
Read MorePatient Survival Prediction
Patient Prognosis Analysis: Accurately Predict Patient Survival Rate
Authentic Estimation of Survival Rates of Patients Based on Their Genetic Footprint
Read MoreLifesaving Technology
Rayca aims to be a foremost, preeminent, acclaimed, and highly influential company that seeks to vigorously propel a unique and ideal set of strategies to treat and hopefully diminish the prevalence of this devastating disease significantly in the not-too-distant future.
- We offer you the assurance of improved clinical decision-making for cancer patients and an increased possibility of finding a cure for cancer diseases in the future.
